Novartis Institutes For Biomedical Research President Mark Fishman: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Fishman discusses his take on how metabolic drug development will change in the future, challenges in developing RNAi-based treatments and the role of federally funded research in innovation.